Center for Digestive and Liver Diseases, Inc.  © 2013  |  Privacy policy

like us

Crohn's Disease

Protocol C87075


SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry.


The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 4000 patients and it's objective is to monitor patients for approximately 10 years.





I am interested in more information about this study.